A carregar...
Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
Obeticholic acid (OCA) is exemplified as a potent drug for treating primary biliary cirrhosis and nonalcoholic fatty liver disease by inhibiting bile acid synthesis. However, it remains unclear whether the effect of OCA is mediated by the function of brown adipose tissue (BAT). In the present study,...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311225/ https://ncbi.nlm.nih.gov/pubmed/34345273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10423 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|